| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab2f8d6e3e2d5497559174b67842c155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
2000-06-05^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23e88fd46833914db769d1e5f9698902 |
| publicationDate |
2000-12-14^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0075135-A1 |
| titleOfInvention |
Biaryl inhibitors of prenyl-protein transferase |
| abstract |
The present invention is directed to compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014009478-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9045445-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016297792-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745377-B2 |
| priorityDate |
1999-06-09^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |